Adagene
ADAG
#9322
Rank
ยฃ70.4 M
Marketcap
ยฃ1.49
Share price
0.00%
Change (1 day)
-5.72%
Change (1 year)

Revenue for Adagene (ADAG)

Revenue in 2024: ยฃ0.07 Million

According to Adagene's latest financial reports the company's current revenue (TTM ) is ยฃ0.07 Million. In 2024 the company made a revenue of ยฃ0.07 Million a decrease over the revenue in the year 2023 that were of ยฃ13.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adagene from 2018 to 2024

Annual revenue

Year Revenue Change
2024ยฃ0.07 M-99.43%
2023ยฃ13.59 M94.9%
2022ยฃ6.97 M-8.67%
2021ยฃ7.63 M1351.71%
2020ยฃ0.52 M46.02%
2019ยฃ0.36 M-68.24%
2018ยฃ1.13 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
ยฃ0.48 B 622,229.56% Jersey
Novavax
NVAX
ยฃ0.76 B 992,429.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
ยฃ0.1 M 39.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
ยฃ16.39 M 21,061.00%๐Ÿ‡ฌ๐Ÿ‡ง UK